Gleolan Interactions
There are 128 drugs known to interact with Gleolan (aminolevulinic acid), along with 3 disease interactions. Of the total drug interactions, 127 are major, and 1 is moderate.
- View Gleolan disease interactions (3)
Medications known to interact with Gleolan
Note: Showing generic names only.
A
- acetazolamide
- acetohexamide
- acitretin
- adapalene topical
- afatinib
- alectinib
- alitretinoin topical
- aminolevulinic acid topical
- amiodarone
- avapritinib
B
C
- capmatinib
- celecoxib
- cetuximab
- chlorothiazide
- chlorpromazine
- chlorpropamide
- chlorthalidone
- cinoxacin
- ciprofloxacin
- coal tar topical
- cobimetinib
D
E
F
G
H
I
K
L
M
- meclocycline sulfosalicylate topical
- mesoridazine
- methdilazine
- methotrexate
- methotrimeprazine
- methoxsalen
- methoxsalen topical
- methyclothiazide
- methyl aminolevulinate topical
- metolazone
- minocycline
- minocycline topical
- moxifloxacin
N
O
P
- palovarotene
- panitumumab
- perphenazine
- pirfenidone
- polythiazide
- porfimer
- prochlorperazine
- promazine
- promethazine
- propiomazine
R
S
- sarecycline
- simeprevir
- sparfloxacin
- st. john's wort
- sulfadiazine
- sulfadoxine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
T
- tazarotene topical
- tetracycline
- tetracycline topical
- thiethylperazine
- thioridazine
- tigecycline
- tipranavir
- tolazamide
- tolbutamide
- torsemide
- tovorafenib
- tretinoin
- tretinoin topical
- trichlormethiazide
- trifarotene topical
- trifluoperazine
- triflupromazine
- trimeprazine
- trioxsalen
- trovafloxacin
V
Gleolan disease interactions
There are 3 disease interactions with Gleolan (aminolevulinic acid) which include:
More about Gleolan (aminolevulinic acid)
- Gleolan consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- FDA approval history
- Drug class: malignancy photosensitizers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.